Showing results (1171-1180 of 5,224) with videos related to
Sort By:
Pageof 523
Antiviral Research|June 20, 2024
RBD design increases the functional antibody titers elicited by SARS-CoV-2 spike vaccinationThayne H Dickey, Nichole D Salinas, Palak Patel, et al.Antiviral Research|November 20, 2023
Monoglycosylated SARS-CoV-2 receptor binding domain fused with HAstem-scaffolded protein vaccine confers broad protective immunity against SARS-CoV-2 and influenza virusesChia-Ying Wu, Yung-Chieh Tseng, Shao-En Kao, et al.Antiviral Research|March 30, 2024
New conjugates based on N4-hydroxycytidine with more potent antiviral efficacy in vitro than EIDD-2801 against SARS-CoV-2 and other human coronavirusesAndrei E Siniavin, Vladimir A Gushchin, Natal'ya S Shastina, et al.Antiviral Research|March 23, 2024
Progress in novel delivery technologies to improve efficacy of therapeutic antibodiesWenli Sun, Yanling Wu, Tianlei YingAntiviral Research|April 1, 2024
Supplementation of seasonal vaccine with multi-subtype neuraminidase and M2 ectodomain virus-like particle improves protection against homologous and heterologous influenza viruses in aged miceJannatul Ruhan Raha, Ki-Hye Kim, Noopur Bhatnagar, et al.Antiviral Research|August 11, 2023
Resistance profiles for the investigational neuraminidase inhibitor AV5080 in influenza A and B virusesAndrei A Ivashchenko, Jeremy C Jones, Dmitry O Shkil, et al.Antiviral Research|August 10, 2023
Diketo acid inhibitors of nsp13 of SARS-CoV-2 block viral replicationAngela Corona, Valentina Noemi Madia, Riccardo De Santis, et al.Antiviral Research|January 25, 2024
Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactomeMariia S Bogacheva, Suvi Kuivanen, Swapnil Potdar, et al.Antiviral Research|January 8, 2024
Assessment of the broad-spectrum host targeting antiviral efficacy of halofuginone hydrobromide in human airway, intestinal and brain organotypic modelsInés García-Rodríguez, Giulia Moreni, Pamela E Capendale, et al.Antiviral Research|January 6, 2024
Genetically modified pigs lacking CD163 PSTII-domain-coding exon 13 are completely resistant to PRRSV infectionBrianna Salgado, Rafael Bautista Rivas, Derek Pinto, et al.Pageof 523